The drug is Gleevec and it really has changed the treatment of chronic myelogenous leukemia dramatically. I was involved from a regulatory end in its approval for use in the US. It isn't a cure, but it is a treatment that is better tolerated than the previous standard therapy and people have responded to it for many years.